Free Trial

IFM Investors Pty Ltd Buys Shares of 41,177 Bath & Body Works, Inc. (NYSE:BBWI)

Bath & Body Works logo with Retail/Wholesale background

IFM Investors Pty Ltd bought a new position in Bath & Body Works, Inc. (NYSE:BBWI - Free Report) in the first quarter, according to the company in its most recent disclosure with the SEC. The fund bought 41,177 shares of the company's stock, valued at approximately $1,314,000.

Other large investors have also added to or reduced their stakes in the company. Smartleaf Asset Management LLC grew its position in shares of Bath & Body Works by 135.0% during the 4th quarter. Smartleaf Asset Management LLC now owns 1,013 shares of the company's stock valued at $39,000 after acquiring an additional 582 shares during the period. Steward Partners Investment Advisory LLC lifted its stake in shares of Bath & Body Works by 17.1% during the 4th quarter. Steward Partners Investment Advisory LLC now owns 4,216 shares of the company's stock valued at $163,000 after buying an additional 615 shares in the last quarter. Charles Schwab Investment Management Inc. lifted its stake in shares of Bath & Body Works by 13.0% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 1,704,625 shares of the company's stock valued at $66,088,000 after buying an additional 195,813 shares in the last quarter. Victory Capital Management Inc. lifted its stake in shares of Bath & Body Works by 25.2% during the 4th quarter. Victory Capital Management Inc. now owns 45,834 shares of the company's stock valued at $1,777,000 after buying an additional 9,215 shares in the last quarter. Finally, M&T Bank Corp lifted its stake in shares of Bath & Body Works by 20.3% during the 4th quarter. M&T Bank Corp now owns 17,688 shares of the company's stock valued at $686,000 after buying an additional 2,984 shares in the last quarter. Institutional investors own 95.14% of the company's stock.

Bath & Body Works Stock Down 1.4%

Bath & Body Works stock traded down $0.48 during midday trading on Wednesday, reaching $33.03. The stock had a trading volume of 5,959,189 shares, compared to its average volume of 5,213,237. Bath & Body Works, Inc. has a 52-week low of $24.94 and a 52-week high of $41.87. The firm has a market cap of $6.99 billion, a price-to-earnings ratio of 8.81, a price-to-earnings-growth ratio of 1.10 and a beta of 1.72. The company has a fifty day moving average of $29.93 and a 200 day moving average of $32.62.

Bath & Body Works (NYSE:BBWI - Get Free Report) last posted its quarterly earnings data on Thursday, May 29th. The company reported $0.49 earnings per share for the quarter, topping analysts' consensus estimates of $0.47 by $0.02. The company had revenue of $1.40 billion for the quarter, compared to analyst estimates of $1.42 billion. Bath & Body Works had a net margin of 11.10% and a negative return on equity of 47.44%. The firm's revenue for the quarter was up 2.9% on a year-over-year basis. During the same period in the prior year, the company posted $0.38 EPS. Equities research analysts predict that Bath & Body Works, Inc. will post 3.3 EPS for the current year.

Bath & Body Works Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Friday, June 20th. Stockholders of record on Friday, June 6th were paid a dividend of $0.20 per share. The ex-dividend date was Friday, June 6th. This represents a $0.80 dividend on an annualized basis and a dividend yield of 2.42%. Bath & Body Works's dividend payout ratio is presently 21.33%.

Analyst Ratings Changes

A number of research analysts recently weighed in on BBWI shares. Piper Sandler set a $39.00 target price on shares of Bath & Body Works and gave the company an "overweight" rating in a research note on Thursday, May 15th. Barclays decreased their price target on shares of Bath & Body Works from $35.00 to $30.00 and set an "equal weight" rating on the stock in a research note on Friday, May 30th. UBS Group boosted their price target on shares of Bath & Body Works from $32.00 to $36.00 and gave the stock a "neutral" rating in a research note on Tuesday, May 20th. JPMorgan Chase & Co. boosted their price target on shares of Bath & Body Works from $41.00 to $43.00 and gave the stock an "overweight" rating in a research note on Monday, May 19th. Finally, Telsey Advisory Group reiterated an "outperform" rating and issued a $38.00 price target (down previously from $43.00) on shares of Bath & Body Works in a research note on Thursday, May 29th. Four equities research analysts have rated the stock with a hold rating and fourteen have assigned a buy rating to the company's stock. Based on data from MarketBeat.com, Bath & Body Works has a consensus rating of "Moderate Buy" and an average target price of $42.00.

Read Our Latest Research Report on Bath & Body Works

Bath & Body Works Profile

(Free Report)

Bath & Body Works, Inc is a specialty retailers and home to America's Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.

Featured Articles

Institutional Ownership by Quarter for Bath & Body Works (NYSE:BBWI)

Should You Invest $1,000 in Bath & Body Works Right Now?

Before you consider Bath & Body Works, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Bath & Body Works wasn't on the list.

While Bath & Body Works currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks to Buy And Hold Forever Cover

Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Don’t Miss These Top 3 Defense Stocks Set To Gain
Triple-Digit Gains: These 4 Nuclear Stocks Have Even More Upside Ahead
3 Made in America Stocks Under $20 You Need to See!

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines